NCI Drug Dictionary - National Cancer Institute
NCI Drug Dictionary drugs/agents used to treat patients with cancer or conditions related to cancer..Cancer-related terms.Dictionary of Cancer Terms more

ACS :: Breast Cancer Drug Approved for Prostate Cancer
The Food and Drug Administration has approved the chemotherapy drug Taxotere (docetaxel) for men with advanced prostate cancer that is not responding to hormone therapy. more

Drug Development and Approval - National Cancer Institute
Information about specific drugs and about drug development and approval. to approved oncology drugs, oncology drug approval processes, regulatory more

ACS :: New Cancer Drugs Offered Hope in 2004
In 2004, researchers from around the world reported progress against the 4 the drug docetaxel, as a treatment for men with advanced prostate cancer that no more

Approved Oncology Drugs
Drugs Advisory Committee Meetings search by .Oncology Tools on cancer drugs, please see the National Institute of Cancer's Drug Information Summaries more

Cancer Drugs: Weighing the Risks and Benefits
cancer drugs to decide on approving or not approving a drug, and cancer patients Food and Drug Administration weighs the risks and benefits of drugs designed to more

Cancer-Drug.com: cancer- questions prevention symptoms
Drug News. has approved the first drug to increase survival in patients Drugs & Treatments Home.Women's Health Home.Diet & Weight Loss.Balance.Fitness more

FDA Approves Prostate Cancer Drug
The disease state of cancer, the medications used to treat it and their actions and interactions with Kit.Medication Therapy Management.Top 200 Drugs more

Cancer - Drug Topics
Breast cancer drugs that debuted from 1997 to 2001 have boosted metastatic Arimidex, the biological drug Herceptin, and the chemotherapy drugs Navelbine, more

Newer Breast Cancer Drugs Aid Survival
use this drug index to learn more about drugs used to treat colorectal cancer. cancer and can be administered by itself or with other chemotherapy drugs. more

GPC Biotech Wins Licensing Dispute With Spectrum on Cancer Drug

Bloomberg - Nov. 6 (Bloomberg) -- GPC Biotech AG, the biotechnology company whose lead drug failed advanced testing earlier this year, won a licensing dispute with Spectrum Pharmaceuticals Inc., avoiding payments of a share of upfront fees. The American ... more

Reuters - BANGALORE (Reuters) - Drugmaker Novacea Inc ended a late-stage trial of its prostate cancer drug Asentar, after a treatment arm containing the drug showed a higher death rate compared with the standard care, driving shares down more than 69 percent ... more